NCT00113113View on ClinicalTrials.gov

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 31, 2001

Conditions
Tumors
Interventions
DRUG

Rubitecan

Trial Locations (2)

63110

Washington University School of Medicine, St Louis

63141

The Center for Cancer Care and Research, St Louis

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY